These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 26256900
21. High expression of the bile salt-homeostatic hormone fibroblast growth factor 19 in the liver of patients with extrahepatic cholestasis. Schaap FG, van der Gaag NA, Gouma DJ, Jansen PL. Hepatology; 2009 Apr; 49(4):1228-35. PubMed ID: 19185005 [Abstract] [Full Text] [Related]
22. The human gallbladder secretes fibroblast growth factor 19 into bile: towards defining the role of fibroblast growth factor 19 in the enterobiliary tract. Zweers SJ, Booij KA, Komuta M, Roskams T, Gouma DJ, Jansen PL, Schaap FG. Hepatology; 2012 Feb; 55(2):575-83. PubMed ID: 21953282 [Abstract] [Full Text] [Related]
23. Pharmacological activation of the bile acid nuclear farnesoid X receptor is feasible in patients with quiescent Crohn's colitis. van Schaik FD, Gadaleta RM, Schaap FG, van Mil SW, Siersema PD, Oldenburg B, van Erpecum KJ. PLoS One; 2012 Feb; 7(11):e49706. PubMed ID: 23189156 [Abstract] [Full Text] [Related]
24. Suppression of Hepatic Bile Acid Synthesis by a non-tumorigenic FGF19 analogue Protects Mice from Fibrosis and Hepatocarcinogenesis. Gadaleta RM, Scialpi N, Peres C, Cariello M, Ko B, Luo J, Porru E, Roda A, Sabbà C, Moschetta A. Sci Rep; 2018 Nov 21; 8(1):17210. PubMed ID: 30464200 [Abstract] [Full Text] [Related]
26. Comparison of fibroblast growth factor 19 concentrations between dogs with and without gallbladder mucoceles. Truong VNY, Liu CC, Myers J, Miller M, Yang A, Lee J, Welborn N, Johnston AN. J Vet Intern Med; 2024 Nov 21; 38(5):2518-2522. PubMed ID: 39134090 [Abstract] [Full Text] [Related]
27. A role for fibroblast growth factor 19 and bile acids in diabetes remission after Roux-en-Y gastric bypass. Gerhard GS, Styer AM, Wood GC, Roesch SL, Petrick AT, Gabrielsen J, Strodel WE, Still CD, Argyropoulos G. Diabetes Care; 2013 Jul 21; 36(7):1859-64. PubMed ID: 23801799 [Abstract] [Full Text] [Related]
28. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis. Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, le Roux CW. Clin Gastroenterol Hepatol; 2009 Nov 21; 7(11):1189-94. PubMed ID: 19426836 [Abstract] [Full Text] [Related]
29. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. Brandl K, Hartmann P, Jih LJ, Pizzo DP, Argemi J, Ventura-Cots M, Coulter S, Liddle C, Ling L, Rossi SJ, DePaoli AM, Loomba R, Mehal WZ, Fouts DE, Lucey MR, Bosques-Padilla F, Mathurin P, Louvet A, Garcia-Tsao G, Verna EC, Abraldes JG, Brown RS, Vargas V, Altamirano J, Caballería J, Shawcross D, Stärkel P, Ho SB, Bataller R, Schnabl B. J Hepatol; 2018 Aug 21; 69(2):396-405. PubMed ID: 29654817 [Abstract] [Full Text] [Related]
34. The Enterokine Fibroblast Growth Factor 15/19 in Bile Acid Metabolism. Cariello M, Piglionica M, Gadaleta RM, Moschetta A. Handb Exp Pharmacol; 2019 Jun 21; 256():73-93. PubMed ID: 31123830 [Abstract] [Full Text] [Related]
38. Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis. Byun S, Kim DH, Ryerson D, Kim YC, Sun H, Kong B, Yau P, Guo G, Xu HE, Kemper B, Kemper JK. Nat Commun; 2018 Jul 03; 9(1):2590. PubMed ID: 29968724 [Abstract] [Full Text] [Related]
39. A nontumorigenic variant of FGF19 treats cholestatic liver diseases. Luo J, Ko B, Elliott M, Zhou M, Lindhout DA, Phung V, To C, Learned RM, Tian H, DePaoli AM, Ling L. Sci Transl Med; 2014 Jul 30; 6(247):247ra100. PubMed ID: 25080475 [Abstract] [Full Text] [Related]